中国药物警戒
中國藥物警戒
중국약물경계
Chinese Journal of Pharmacovigilance
2015年
9期
522-525
,共4页
宋金波%宋丹丹%沈佳伟%周玮丽%褚菲菲%施红%邵贵强%曹秀琴
宋金波%宋丹丹%瀋佳偉%週瑋麗%褚菲菲%施紅%邵貴彊%曹秀琴
송금파%송단단%침가위%주위려%저비비%시홍%소귀강%조수금
高压氧%盐酸二甲双胍%药代动力学%高效液相色谱法
高壓氧%鹽痠二甲雙胍%藥代動力學%高效液相色譜法
고압양%염산이갑쌍고%약대동역학%고효액상색보법
hyperbaric oxygen%metformin hydrochloride%pharmac okinetics%HPLC
目的:研究高压氧(HBO)对盐酸二甲双胍(MET)药代动力学的影响。方法200只小鼠随机分成对照组104只,和高压氧组(HBO组)96只,2组均按150 mg·kg-1剂量单次灌服盐酸二甲双胍溶液。HBO组灌服后立即置于高压氧舱,稳压(0.20 MPa)吸纯氧20 min,升压、减压各5 min;对照组仅单次灌服盐酸二甲双胍溶液。2组在给药前及给药后不同时间点各取8只小鼠,球后静脉丛取血,采用高效液相色谱法测定血浆中MET的浓度,计算药代动力学参数。结果HBO组峰浓度(Cmax)、达峰时间(tmax)、血浆半衰期(t1/2)、平均血药浓度一时间曲线下面积(AUC)、清除率(CL/F)和表观分布容积(Vd)分别为:(9.64±2.94)μg·mL-1、(0.42±0.12)h、(5.28±0.78)h、(29.76±5.21)μg·h·mL-1、(4.94±0.65)L·h-1·kg-1、(12.46±3.17)L·kg-1;对照组分别为:(18.68±4.26)μg·mL-1、(0.10±0.04)h、(7.41±1.06)h、(44.12±7.15)μg·h·mL-1、(3.32±0.63)L·h-1·kg-1、(7.62±1.97)L·kg-1。结论HBO可以明显加快小鼠体内MET的消除,对药代动力学参数有明显的影响。
目的:研究高壓氧(HBO)對鹽痠二甲雙胍(MET)藥代動力學的影響。方法200隻小鼠隨機分成對照組104隻,和高壓氧組(HBO組)96隻,2組均按150 mg·kg-1劑量單次灌服鹽痠二甲雙胍溶液。HBO組灌服後立即置于高壓氧艙,穩壓(0.20 MPa)吸純氧20 min,升壓、減壓各5 min;對照組僅單次灌服鹽痠二甲雙胍溶液。2組在給藥前及給藥後不同時間點各取8隻小鼠,毬後靜脈叢取血,採用高效液相色譜法測定血漿中MET的濃度,計算藥代動力學參數。結果HBO組峰濃度(Cmax)、達峰時間(tmax)、血漿半衰期(t1/2)、平均血藥濃度一時間麯線下麵積(AUC)、清除率(CL/F)和錶觀分佈容積(Vd)分彆為:(9.64±2.94)μg·mL-1、(0.42±0.12)h、(5.28±0.78)h、(29.76±5.21)μg·h·mL-1、(4.94±0.65)L·h-1·kg-1、(12.46±3.17)L·kg-1;對照組分彆為:(18.68±4.26)μg·mL-1、(0.10±0.04)h、(7.41±1.06)h、(44.12±7.15)μg·h·mL-1、(3.32±0.63)L·h-1·kg-1、(7.62±1.97)L·kg-1。結論HBO可以明顯加快小鼠體內MET的消除,對藥代動力學參數有明顯的影響。
목적:연구고압양(HBO)대염산이갑쌍고(MET)약대동역학적영향。방법200지소서수궤분성대조조104지,화고압양조(HBO조)96지,2조균안150 mg·kg-1제량단차관복염산이갑쌍고용액。HBO조관복후립즉치우고압양창,은압(0.20 MPa)흡순양20 min,승압、감압각5 min;대조조부단차관복염산이갑쌍고용액。2조재급약전급급약후불동시간점각취8지소서,구후정맥총취혈,채용고효액상색보법측정혈장중MET적농도,계산약대동역학삼수。결과HBO조봉농도(Cmax)、체봉시간(tmax)、혈장반쇠기(t1/2)、평균혈약농도일시간곡선하면적(AUC)、청제솔(CL/F)화표관분포용적(Vd)분별위:(9.64±2.94)μg·mL-1、(0.42±0.12)h、(5.28±0.78)h、(29.76±5.21)μg·h·mL-1、(4.94±0.65)L·h-1·kg-1、(12.46±3.17)L·kg-1;대조조분별위:(18.68±4.26)μg·mL-1、(0.10±0.04)h、(7.41±1.06)h、(44.12±7.15)μg·h·mL-1、(3.32±0.63)L·h-1·kg-1、(7.62±1.97)L·kg-1。결론HBO가이명현가쾌소서체내MET적소제,대약대동역학삼수유명현적영향。
Objective To investigate the effects ofhyperbaric oxygen(HBO)on the pharmacokinetics of MET.Methods Two hundred mice were randomly divided into 2 groups, the HBO group and the control group. The 2 groups of animals received gavage of MET with a single-dose of 150 mg·kg-1. The animals in the HBO group were immediately put into the hyperbaric oxygen chamber and maintained at a pressure of 0.20 MPa for a duration of 20 min. The time used for compression and decompression was both 5 min. The animals in the control group were just given a single gavage of MET. Eight animals from each group were chosen at different time points both before and after drug admin-istration, for collection of blood samples from the eyeballs. Concentrations of MET in serum were monitored with high performance liquid chromatography, and pharmacokinetic indices were calculated accordingly. Results The main pharmaeokinetic parameters of the HBO group were as follows:Cmax (9.64±2.94)μg·mL-1, tmax (0.42±0.12)h, t1/2 (5.28±0.78)h, AUC(29.76±5.21)μg·mL-1·h, CL/F (4.94±0.65)L·h-1·kg-1, Vd (12.46±3.17)L·kg-1, while the corresponding results of the control group were Cmax (18.68±4.26)μg·mL-1, tmax (0.10±0.04)h, t1/2 (7.41±1.06)h, AUC(44.12± 7.15)μg·mL-1·h, CL/F (3.32±0.63)L·h-1·kg-1, Vd (7.62±1.97)L·kg-1. Conclusion HBO could obviously acceler-ate the elimination of MET and seemed to have significant effect on pharmacokinetic parameters.